Showing results (101-110 of 299) with videos related to

Sort By:
Pageof 30
Gene|June 12, 1996
Cloning and characterization of the MamI restriction-modification system from Microbacterium ammoniaphilum in Escherichia coliH M Striebel, S Seeber, M Jarsch, et al.
Deutsche Medizinische Wochenschrift (1946)|May 30, 1980
[Improved antiemetic treatment with levomepromazine (author's transl)]M Higi, N Niederle, C G Schmidt, et al.
Cancer Treatment Reviews|September 1, 1983
Treatment of refractory malignant lymphomas with ifosfamide/etoposide combination chemotherapyM E Scheulen, K Bremer, N Niederle, et al.
Investigational New Drugs|January 1, 1990
Comparative activity of four anthracyclines against heterotransplanted germ cell tumor linesA Harstrick, J Casper, H Köhne-Wömpner, et al.
International Journal of Oncology|May 17, 2011
Metastatic leydig-cell tumors of the testis - report of 4 cases and review of the literatureC Bokemeyer, A Harstrick, O Gonnermann, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 1, 2005
Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation: a study on C225 in FaDu hSCCM Krause, C Schütze, C Petersen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 1992
Epirubicin/dacarbazine rapidly alternated with ifosfamide in the treatment of metastatic soft tissue sarcomasC Bokemeyer, A Harstrick, H J Schmoll, et al.
Langenbecks Archiv Fur Chirurgie|January 1, 1981
[Chemotherapy of soft tissue sarcomas]D K Hossfeld, S Seeber, E Siemers, et al.
Zeitschrift Fur Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology|May 20, 1977
Cytostatic efficacy of DNA-complexes of adriamycin, daunomycin and actinomycin D. I. Comparative studies in Novikoff hepatoma, human mammary carcinoma cells and human leukemic leukocytesS Seeber, K P Brucksch, B Seeber, et al.
Blut|January 1, 1975
[Macronucleolar transformation of a leukemic lymphosarcoma. Clinical morphologic and molecular biologic parameters]S Seeber, M Rodenbeck, K P Brucksch, et al.
Pageof 30